Murphy Pohlad Asset Management LLC Organon & Co. Transaction History

Murphy Pohlad Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$21.42 - $32.08 $1.19 Million - $1.79 Million	-55,684 Reduced 68.93%	25,105 $590,000
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $234,172 - $287,416	10,046 Added 14.2%	80,789 $2.26 Million
Q3 2022 Oct 24, 2022	SELL	$23.4 - $34.25 $43,641 - $63,876	-1,865 Reduced 2.57%	70,743 $1.66 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $37,833 - $46,485	1,195 Added 1.67%	72,608 $2.45 Million
Q1 2022 May 05, 2022	BUY	$30.45 - $39.36 $17,082 - $22,080	561 Added 0.79%	71,413 $2.49 Million
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $18,320 - $23,726	639 Added 0.91%	70,852 $2.16 Million
Q3 2021 Nov 09, 2021	BUY	$28.63 - $35.64 $462,374 - $575,586	16,150 Added 29.87%	70,213 $2.3 Million
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $1.54 Million - $2.05 Million	54,063 New	54,063 $1.64 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.